Silence Therapeutics
SLN
#6719
Rank
S$1.06 B
Marketcap
S$17.10
Share price
-0.22%
Change (1 day)
161.31%
Change (1 year)

EPS for Silence Therapeutics (SLN)

EPS in 2026 (TTM): S-$2.53

According to Silence Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.49. In 2025 the company made an earnings per share (EPS) of S-$2.41 a decrease over its 2024 EPS that were of S-$1.26.

EPS history for Silence Therapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.535.23%
2025S-$2.4190.91%
2024S-$1.26-32.65%
2023S-$1.87-5.77%
2022S-$1.99-13.03%
2021S-$2.2910.23%
2020S-$2.0758.5%
2019S-$1.312.94%
2018S-$1.27969.59%
2017S-$0.12-79.18%
2016S-$0.57-3.11%
2015S-$0.59-55%
2014S-$1.313.83%
2013S-$1.26-84.88%
2012S-$8.34134.19%
2011S-$3.56-61.8%
2010S-$9.32-45.65%
2009S-$17.16-1.16%
2008S-$17.364.29%
2007S-$16.6410.54%
2006S-$15.06-22.29%
2005S-$19.38-57.32%
2004S-$45.4039.1%
2003S-$32.6470.67%
2002S-$19.12-25.17%
2001S-$25.565.29%
2000S-$24.27-24.54%
1999S-$32.1626.7%
1998S-$25.39-11.73%
1997S-$28.7672.24%
1996S-$16.70